Is Creatine Safe for Women? What 10 Years of Research Actually Shows

Every week, I get the same question in my DMs: "But is it actually safe for women?" The short answer is yes — overwhelmingly, unambiguously yes. The longer answer is what this article is about.

Creatine monohydrate is one of the most studied sports supplements in history, with over 500 peer-reviewed studies published since the 1990s. Yet a persistent cloud of doubt follows women who consider taking it. Where does that doubt come from? And what does the science actually say? Let's go through it properly.

1. The Myth That Won't Die

The safety concerns around creatine for women largely trace back to two sources: early studies that used loading protocols with high doses (20–25g/day), and a general cultural assumption that anything marketed to male athletes must be dangerous for women. Neither holds up to scrutiny.

The high-dose loading studies from the 1990s and early 2000s did report some gastrointestinal discomfort and water retention — but these were transient effects at doses far above what is now recommended. Modern research uses 3–5g/day as the standard protocol, and the side effect profile at this dose is essentially identical to placebo.

The second source — the assumption that female physiology makes creatine riskier — is not supported by any mechanistic evidence. Women metabolise creatine through the same biochemical pathway as men (the arginine-glycine amidinotransferase pathway), and the safety endpoints studied in clinical trials show no sex-based differences in adverse events.

2. The Landmark 2020 Safety Review

In 2020, de Guingand and colleagues published what is now considered the definitive safety review of creatine supplementation in women: "Risk of Adverse Outcomes in Females Taking Oral Creatine Monohydrate: A Systematic Review and Meta-Analysis", published in Nutrients.

The researchers systematically searched PubMed, CINAHL, Embase, and Cochrane databases for all randomised controlled trials involving female participants taking oral creatine monohydrate. After applying strict inclusion criteria, they analysed 14 studies involving 469 female participants across a range of ages, health statuses, and supplementation durations.

"No serious adverse events were reported in any of the included studies. The overall risk of adverse outcomes in females taking oral creatine monohydrate was low."

— de Guingand et al., Nutrients, 2020

The review found no increased risk of kidney damage, liver dysfunction, cardiovascular events, hormonal disruption, or any other serious adverse outcome. The only reported side effects were mild and transient: occasional gastrointestinal discomfort in a small subset of participants, typically associated with taking creatine on an empty stomach.

3. What About Your Kidneys?

The kidney concern is the most persistent myth in the creatine space, and it deserves a direct answer. The confusion arises because creatine supplementation raises serum creatinine levels — a standard marker used to assess kidney function. When doctors see elevated creatinine, they flag it as a potential problem. But in creatine users, this elevation is a direct metabolic consequence of supplementation, not a sign of kidney damage.

Creatine is converted to creatinine as a normal part of energy metabolism. When you supplement with creatine, you produce more creatinine — but your kidneys are filtering it perfectly well. The kidneys themselves are not under any additional stress. This distinction is critical and has been confirmed in multiple studies specifically designed to measure actual kidney function (via GFR — glomerular filtration rate) rather than just creatinine as a proxy.

A 2021 review by Ostojic confirmed that creatine supplementation at doses of 3–5g/day does not impair GFR in healthy individuals. The International Society of Sports Nutrition (ISSN) position stand on creatine explicitly states that creatine supplementation does not damage kidneys in healthy individuals. If you have pre-existing kidney disease, consult your doctor before supplementing — but for healthy women, the kidney concern is not supported by evidence.

4. Creatine and Hormones: Does It Affect Oestrogen or Testosterone?

One of the more nuanced questions I receive is whether creatine affects female hormones — particularly oestrogen, progesterone, and testosterone. This is a legitimate question worth examining carefully.

The short answer is: creatine does not directly alter oestrogen or progesterone levels. There is no known mechanism by which creatine monohydrate would interact with the hypothalamic-pituitary-gonadal axis that regulates female sex hormones. The de Guingand 2020 review found no evidence of hormonal disruption across all included studies.

The more interesting finding is that oestrogen appears to influence how well creatine works. Research by Smith-Ryan and colleagues (2021) found that women in the luteal phase of their menstrual cycle — when progesterone is dominant and oestrogen is lower — may experience greater benefits from creatine supplementation on cognitive tasks. This suggests that creatine's effects in women are not static but may vary across the menstrual cycle, which is an active area of research.

For women going through perimenopause or menopause, the relationship becomes even more interesting. Declining oestrogen is associated with reduced creatine synthesis and lower muscle creatine stores. This means postmenopausal women may have more to gain from supplementation than younger women — a finding supported by a 2021 study by Candow et al. showing significant muscle and bone benefits in postmenopausal women taking creatine alongside resistance training.

5. The DHT and Hair Loss Question

This concern comes from a single study published in 2009 by van der Merwe et al., which found that male rugby players taking creatine experienced a 56% increase in DHT (dihydrotestosterone) levels after a loading phase. DHT is associated with androgenic alopecia (pattern hair loss) in genetically predisposed individuals.

Before you close this tab, let me give you the full picture. First, this study has never been replicated. Multiple subsequent studies measuring DHT in creatine users have not found the same effect. Second, the study was conducted in men, using a loading protocol (25g/day for 7 days), and DHT levels remained within the normal physiological range throughout. Third, and most importantly for women: the mechanism of androgenic alopecia in women is fundamentally different from men. Women's hair follicles are far less sensitive to DHT, and female pattern hair loss is primarily driven by oestrogen decline, not DHT elevation.

No study has ever demonstrated creatine-induced hair loss in women. The concern, while understandable given the 2009 study, does not translate to female physiology based on current evidence.

6. Pregnancy and Breastfeeding

This is the one area where the safety picture is genuinely incomplete — not because there is evidence of harm, but because there is insufficient evidence to make a definitive recommendation either way.

Animal studies have actually shown potential benefits of creatine supplementation during pregnancy, including reduced risk of hypoxic injury to the foetus. A 2021 review by Dickinson et al. in Nutrients concluded that creatine supplementation during pregnancy appears safe and potentially beneficial based on preclinical data, but noted that human clinical trials are lacking.

The current consensus position is: if you are pregnant or breastfeeding, consult your healthcare provider before taking creatine. This is a precautionary recommendation based on insufficient data, not on evidence of harm. Many healthcare providers will be comfortable with supplementation given the overall safety profile, but this is a decision to make with your doctor.

7. Safe Dosing Protocol for Women

Based on the current evidence, here is the dosing protocol that is both safe and effective for most women:

One important note: skip the loading phase. Loading protocols (20–25g/day for 5–7 days) were developed to saturate muscle creatine stores quickly, but they are associated with higher rates of gastrointestinal discomfort and water retention. Research shows that 3–5g/day achieves the same muscle saturation within 3–4 weeks — with far fewer side effects. For women who are sensitive to bloating, the lower dose and no-loading approach is the clear recommendation.

8. The Verdict

Creatine monohydrate is one of the safest supplements available for women. The evidence is not ambiguous on this point. The landmark de Guingand 2020 systematic review found zero serious adverse events across 469 female participants. The kidney concern is based on a misunderstanding of creatinine metabolism. The hair loss concern does not translate from male to female physiology. The hormonal concern is not supported by any mechanistic or clinical evidence.

The only genuine caveat is pregnancy and breastfeeding, where the evidence is insufficient for a definitive recommendation — not because of demonstrated harm, but because of a gap in the research. For all other healthy women, the safety profile of creatine monohydrate at 3–5g/day is excellent.

If you have been hesitating because of safety concerns, I hope this article has given you the evidence you needed to make an informed decision. The science is clear. The question now is whether you want to take advantage of it.

References

1. 1. de Guingand DL, et al. (2020). Risk of Adverse Outcomes in Females Taking Oral Creatine Monohydrate: A Systematic Review and Meta-Analysis. Nutrients, 12(6), 1780. doi:10.3390/nu12061780
2. 2. Kreider RB, et al. (2017). International Society of Sports Nutrition position stand: safety and efficacy of creatine supplementation in exercise, sport, and medicine. Journal of the International Society of Sports Nutrition, 14, 18. doi:10.1186/s12970-017-0173-z
3. 3. Smith-Ryan AE, et al. (2021). Creatine Supplementation in Women's Health: A Lifespan Perspective. Nutrients, 13(3), 877. doi:10.3390/nu13030877
4. 4. Candow DG, et al. (2021). Creatine supplementation for older adults: Focus on sarcopenia, osteoporosis, frailty and Cachexia. Bone, 153, 116467. doi:10.1016/j.bone.2021.116467
5. 5. van der Merwe J, et al. (2009). Three weeks of creatine monohydrate supplementation affects dihydrotestosterone to testosterone ratio in college-aged rugby players. Clinical Journal of Sport Medicine, 19(5), 399–404. doi:10.1097/JSM.0b013e3181b8b52f
6. 6. Dickinson H, et al. (2021). Creatine Supplementation during Pregnancy: Summary of Experimental Studies Suggesting a Treatment to Improve Fetal and Neonatal Morbidity and Reduce Mortality in High-Risk Human Pregnancy. BMC Pregnancy and Childbirth, 14, 150. doi:10.1186/1471-2393-14-150